Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study

F (Franco) Locatelli, C Mauz-Koerholz, K Neville, A Llort, Auke Beishuizen, S Daw, M Pillon, N Aladjidi, T Klingebiel, J Landman-Parker, A Medina-Sanson, K August, J Sachs, K Hoffman, J Kinley, S Song, G Song, S Zhang, A Suri, L Gore

Research output: Contribution to journalArticleAcademicpeer-review

84 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)E450-E461
JournalLancet Haematology
Volume5
Issue number10
Publication statusPublished - 2018

Research programs

  • EMC MM-02-54-03

Cite this